A drug selected for the latest round of Medicare drug price negotiations stands to get dropped because a lower-cost ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle ...

The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by negotiating with their manufacturers. Among them is Biktarvy, a drug taken after HIV ...

Beginning this year, Medicare's new negotiated drug prices could cut prescription costs in half for millions of seniors, a ...

In response to last month’s list of the 15 drugs chosen by the Centers for Medicare & Medicaid Services (CMS) for upcoming ...

The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...

Botox and the GLP-1 drug Trulicity are among the latest group of prescription drugs subject to price controls by Medicare. The Centers for Medicare & Medicaid Services (CMS), the federal agency that ...

Fifteen prescription medications will be the focus of federal price negotiations that could lower prices for Medicare patients.

Medicare drug price negotiations kick-started by the Biden administration will finally result in lower drug prices for seniors beginning Jan. 1. The Medicare-negotiated price cuts will apply to 10 ...

While the 15 medications selected for the latest round of the federal government’s drug price negotiation program will face steep cuts in what Medicare will pay, the financial impact to pharmaceutical ...